Happy Holidays!
Up front, my apologies for being redundant. This first Pharmalot post is from February [on the right track…]. I just thought Ed’s post today needed the background to make sense of this story: A Tough Push For Clinical Trial Disclosure In Europe Pharmalot By Ed Silverman February 4th, 2013 As the debate over clinical trial […]
2003 was a long time ago for me. It was the year I retired from practice, sold my house in Atlanta, and moved to the mountains. It was also the year Jon Jureidini first wrote the JAACAP about the Paxil® Study 329 article, but I didn’t know about that then. I did, however, know about […]
I report here only the conclusions from this article in the BMJ. I didn’t purloin the whole article, not because of copyright restrictions, but to support subscribing to this journal. It’s my only paid subscription, even though I have free emeritus faculty access. Editor Fiona Godlee has emerged along with Marcia Angell as the editors […]
Yesterday, I worked in the clinic, and I kept thinking about the old saying, "shutting the stable door after the horse has bolted" [in East Tennessee it was "closing the barn door after the cows ran off" but the spirit’s the same]. In psychiatry, the pipeline’s empty, and we have about all the SSRIs/SNRIs and […]
Beware the fine print of Glaxo’s big drug-marketing announcement The Week by Peter Weber December 17, 2013 On Tuesday, British drugmaker GlaxoSmithKline vowed to unilaterally disarm in the controversial marketing war that has helped fuel the pharmaceutical industry’s robust growth in the past 30 years. This is potentially a big step toward curbing conflicts of […]
GSK to stop paying doctors in overhaul of sales practices Reuters By Ben Hirschler Dec 17, 2013 GlaxoSmithKline will stop paying doctors for promoting its drugs and scrap prescription targets for its marketing staff – a first for an industry battling scandals over its sales practices, and a challenge for its peers to follow suit. […]
Money and Medical Journals PharmedOut Medical Behavior in a Commercial World: Who is Responsible? by Marcia Angell MD, Harvard University June 6-7, 2013 Most medical journals that publish reports of clinical research are owned by professional societies. Some are distributed to members for free; others are available by subscription. Some lose money for their owners; […]
Kaler on Faculty Senate resolution: "It’s not a review of the Markingson case" Fear and Loathing in Bioethics by Carl Elliot December 11, 2013 I think we’re getting a pretty good idea of where the University of Minnesota administration plans to take the "independent review" endorsed by the Faculty Senate last week. This interview with […]
BLOGSCAN – US Supreme Court Turns Down Pfizer Appeal of RICO Conviction Healthcare Renewal by Roy Poses December 13, 2013 Pfizer Inc, which boasts of being the world’s largest research based pharmaceutical company, also seems to be one of the world’s largest examples of health care corporations that have withstood an amazing number of settlements, […]